ClinicalTrials.gg
Drug

Bifeprunox clinical trials

Also written DU 127090.

studies test it
19
open now
0
in phase 3
14
first study started
2005

How each study uses bifeprunox is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Bifeprunox
18

Development codes

DU 127090
2

Studies by the year they started

19 studies that test it; most in 2005 (9)

Studies that test bifeprunox, by start year
YearStudies
20059
20065
20073
20082

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
4
Phase 3
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 19 · Other 0

Solvay Pharmaceuticals (9) · Wyeth is now a wholly owned subsidiary of Pfizer (7) · H. Lundbeck A/S (3)

Often tested with

Tested in the same studies.

Olanzapine (1)

Studies

Open first, then newest update. How each study uses bifeprunox is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Codes

What other systems call bifeprunox · ClinicalTrials.gg INT004908

  • MeSH (NLM) C509981bifeprunoxOne source NLM
  • UNII (FDA) AP69E83Z79BIFEPRUNOXConfirmed FDA, NLM, Wikidata
  • Wikidata Q4904729bifeprunoxConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65262BifeprunoxOne source FDA
  • DrugBank DB04888One source Wikidata

Also registered as bifeprunox mesylate (UNII 8F018D8L02).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.